Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds

Area of Science:

• Molecular Biology
• Virology
• Medicinal Chemistry

Background:

• The HIV-1 Rev protein is crucial for viral replication, regulating the transport of viral RNAs.
• Rev's function depends on binding to the Rev responsive element (RRE) on viral RNA.
• Blocking the Rev-RRE interaction is a key strategy for developing anti-HIV drugs.

Purpose of the Study:

• To identify small molecules that inhibit the Rev-RRE interaction.
• To investigate the mechanism of inhibition by novel compounds.
• To explore the potential of targeting RNA-protein interactions for antiviral therapy.

Main Methods:

• Screening of aromatic heterocyclic compounds for Rev-RRE binding inhibition.
• Characterization of the binding interaction between AK.A and the Rev binding site.
• Structure-activity relationship analysis of inhibitory compounds.

Main Results:

• A tetracationic diphenylfuran, AK.A, was found to potently inhibit Rev-RRE interaction at 0.1 microM.
• AK.A competitively binds to a specific site within the Rev RNA binding site.
• The binding mechanism of AK.A differs from existing aminoglycoside inhibitors.
• Stereospecific features of compounds are critical for inhibitory activity.

Conclusions:

• Aromatic heterocyclic compounds, exemplified by AK.A, can effectively block the essential HIV-1 Rev-RRE interaction.
• AK.A represents a novel class of potential anti-HIV agents targeting RNA-protein interactions.
• This study validates the approach of designing small molecules to disrupt specific viral RNA-protein binding events.